Market Research Logo

European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021)

European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021)

Scope of the Report

The report entitled “European ICU Sedation Drugs Market: Size, Trends & Forecasts (2017-2021)”, provides analysis of Europe ICU sedation drugs market, with detailed analysis of market size and growth, and segmentation of the industry. The analysis of the European ICU sedation drugs market includes the market by value and by segments.

Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the overall the Europe ICU sedation drugs market has also been forecasted for the years 2017-2021, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.

Aspen Pharmacare, Perrigo, Orion Corporation and Primex Pharmaceuticals are some of the key players operating in the Europe ICU sedation drugs market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.

Company Coverage

Aspen Pharmacare
Perrigo
Orion Corporation
Primex Pharmaceuticals

  Executive Summary

Sedation is described as the action of reducing apprehension, stress, irritability or excitement by administration of a sedative agent or drug. A sedative is a medication that commonly induces into nervous system to calm and to relax. Significantly, sedation is utilized as a part of minor surgeries like dentistry, some corrective surgeries or to deal with high tension patients. Sedation is accomplished along a continuum of sedation levels: minimal sedation, moderate sedation, deep sedation and general anesthesia.

The pathway by which a medicine or liquid is entered into the body is called as route of administration. Sedatives are administered through various medium namely; inhalation, tablets, injections, or Intravenous (IVs). Commonly used route of administration are Intravenous (IVs) and Inhalation.

An intravenous route used a venipuncture as a means of injecting central nervous system depressants into the bloodstream. The major intravenous anesthetic drugs are: Remifentanil, Midazolam, Propofol and Dexmedetomidine

An inhalational sedation uses inhalable route of administration, through an anesthesia mask, laryngeal mask airway or tracheal tube connected to an anesthetic and an anesthetic delivery system like AnaConDa and Mirus. The major inhalational sedation or anesthetic agents that uses inhalable route of administration are: Sevoflurane, Isoflurane and Desflurane.

The Europe ICU sedation drugs market is expected to increase at high growth rates during the forecasted period (2017-2021). The Europe ICU sedation drugs market is supported by various growth drivers, rising geriatric population, adoption of sedentary lifestyle, increasing number of surgeries, increasing healthcare expenditure, etc. Some challenges that hinder the growth are adverse effects of sedative drugs, lack of trained healthcare providers and environmental issues, etc.


1. Executive Summary
2. Introduction
2.1 Sedation: An Overview
Table 1: Continuum of Sedation Levels
2.2 ICU Sedation Drugs Routes of Administration
Table 2: ICU Sedation Drugs Routes of Administration
2.2.1 Inhalable Route
2.2.2 Intravenous Route
2.2.3 Oral Route
2.3 Advantages & Disadvantages of ICU Sedation Drugs
2.3.1 Advantages
2.3.2 Disadvantages
3. Europe Market Analysis
3.1 Europe ICU Sedation Drugs Market: An Overview
3.1.1 Europe ICU Sedation Drugs Market by Value
Table 3: Europe ICU Sedation Drugs Market by Value; 2013-2016 (US$ Million)
Table 4: Europe ICU Sedation Drugs Market by Value; 2017-2021 (US$ Million)
3.1.2 Europe ICU Sedation Drugs Market by Segment
Table 5: Europe ICU Sedation Drugs Market by Segment; 2016-2017
3.2 Europe ICU Sedation Drug Market: Segment Analysis
3.2.1 Europe Propofol ICU Sedation Drug Market by Value
Table 6: Europe Propofol ICU Sedation Drug Market by Value; 2013-2016 (US$ Million)
3.2.2 Europe Dexmedetomidine ICU Sedation Drugs Market by Value
Table 7: Europe Dexmedetomidine ICU Sedation Drugs Market by Value; 2013-2016 (US$ Million)
3.2.3 Europe Midazolam ICU Sedation Drugs Market by Value
Table 8: Europe Midazolam ICU Sedation Drugs Market by Value; 2013-2016
(US$ Million)
3.2.4 Europe Remifentanil ICU Sedation Drugs Market by Value
Table 9: Europe Remifentanil ICU Sedation Drugs Market by Value; 2013-2016 (US$ Million)
3.3 Europe ICU Sedation Device Market: An Overview
3.3.1 Europe ICU Sedation Device Market by AnaConDa Device Volume
Table 10: Europe ICU Sedation Device Market by AnaConDa Device Volume; 2012-2016 (Thousand)
Table 11: Europe ICU Sedation Device Market by AnaConDa Device Volume; 2017-2021 (Thousand)
3.3.2 Europe ICU Sedation Device Market by AnaConDa Device Value
Table 12: Europe ICU Sedation Device Market by AnaConDa Device Value; 2012-2016 (US$ Million)
Table 13: Europe ICU Sedation Device Market by AnaConDa Device Value; 2017-2021 (US$ Million)
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Rising Geriatric Population
Table 14: Europe Geriatric Population; 2012-2016 (Million)
4.1.2 Adoption of Sedentary Lifestyle
Table 15: Europe Urban Population; 2012-2016 (Million)
4.1.3 Rising Healthcare Expenditure
Table 16: Europe Health expenditure per capita; 2012-2015 (US$)
4.1.4 Growing Incidence Rates Of Chronic Diseases
4.1.5 Increasing Number Of Surgeries
4.2 Challenges
4.2.1 Adverse Effects of Sedative Drugs
4.2.2 Lack of Trained Healthcare Providers
4.2.3 Environmental Implications
4.2.4 High Cost Associated with ICU Stay
4.3 Market Trends
4.3.1 Waste Anesthetic Gas Disposal System (WAGD)
4.3.2 Favorable Reimbursement Policy
5. Competitive Landscape
5.1 Europe ICU Sedation Drugs Market Players Financial Comparison
Table 17: Europe ICU Sedation Drugs Market Players Financial Comparison; 2016 (US$ Billion)
5.2 ICU Sedation Drugs Market Players Product Comparison
Table 18: ICU Sedation Drugs Market Players Product Overview
6. Company Profiling
6.1 Aspen Pharmacare
6.1.1 Business Overview
6.1.2 Financial Overview
Table 19: Aspen Pharmacare Revenue; 2012-2016 (US$ Billion)
Table 20: Aspen Pharmacare Revenue by Segments; 2016
6.1.3 Business Strategy
6.2 Perrigo
6.2.1 Business Overview
6.2.2 Financial Overview
Table 21: Perrigo Net Sales; 2012-2016 (US$ Billon)
Table 22: Perrigo Net Sales by Segments; 2016
Table 23: Perrigo Net Sales by Region; 2016
6.2.3 Business Strategy
6.3 Orion Corporation
6.3.1 Business Overview
6.3.2 Financial Overview
Table 24: Orion Corporation Net Sales; 2012-2016 (US$ Billion)
Table 25: Orion Corporation Net Sales by Segments; 2016
Table 26: Orion Corporation Net Sales by Region; 2016
6.3.3 Business Strategy
6.4 Primex Pharmaceuticals
6.4.1 Business Overview
6.4.2 Business Strategy

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report